MAX-20492

N/A

Report date: 2024/05/16 17:42:20
NME

Base Information

Drug NameMAX-20492
Drug Alias NameMAX-2MAX-20492
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo)
Mechanisms of ActionProgrammed death-ligand 1 modulators
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMaxiNovel Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMaxiNovel Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A